Product Information
VARDENAFIL HCL 10 MG ODT is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $23.3270 per EA under NDC 33342020337. Its NADAC has been published 116 times since Jul 17, 2024.
FDA first approved this application on Mar 10, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
11.85 mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342020337
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VARDENAFIL HYDROCHLORIDE TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205988FDA Approved
3/10/2020
TE Code
AB
On Market Since
10/26/2018
Pharmacological Classes
Price Statistics
The NADAC for VARDENAFIL HCL 10 MG ODT has been published 116 times since Jul 17, 2024, and over the history we have for it it has risen 7.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $23.3270 per EA |
|---|---|
| All-time high | $26.9875 (Jun 11, 2025) |
| All-time low | $18.8963 (Jan 21, 2026) |
| 52-week high | $25.1161 |
| 52-week low | $18.8963 |
| Median price | $22.7164 |
| Average price | $23.0230 |
| Largest weekly change | -16.6% (Jun 18, 2025) |
| Weeks tracked | 116 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Vardenafil market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Vardenafil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 5 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VARDENAFIL HCL 10 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for VARDENAFIL HCL 10 MG ODT, manufactured by Macleods Pharmaceuticals Limited, is $23.3270 per EA (NDC 33342020337), effective Sep 30, 2026.
How has the price of VARDENAFIL HCL 10 MG ODT changed over time?
Over the history we have for it, the NADAC for VARDENAFIL HCL 10 MG ODT has risen 7.2%. It has been tracked across 116 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for VARDENAFIL HCL 10 MG ODT?
Since Jul 17, 2024, the NADAC for VARDENAFIL HCL 10 MG ODT has ranged from a low of $18.8963 (Jan 21, 2026) to a high of $26.9875 (Jun 11, 2025), with a median of $22.7164 per EA.
Are there cheaper alternatives to VARDENAFIL HCL 10 MG ODT?
No other NADAC-published product currently shares the active ingredient and strength of VARDENAFIL HCL 10 MG ODT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VARDENAFIL HCL 10 MG ODT?
VARDENAFIL HCL 10 MG ODT (NDC 33342020337) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.